Elicit and the End of Manual Evidence Matrices in Regulatory Submissions
How Elicit’s AI-Driven Discovery & Matrix Extraction Platform Transforms Regulatory Evidence Workflows Elicit is an AI-powered research platform that supports regulatory and evidence work by discovering, summarising, and extracting structured data from large volumes of scientific and clinical literature, with a particular strength in generating matrix-style evidence tables. It addresses the bottleneck of manual literature […]
Feature Categories
How Elicit’s AI-Driven Discovery & Matrix Extraction Platform Transforms Regulatory Evidence Workflows
Elicit is an AI-powered research platform that supports regulatory and evidence work by discovering, summarising, and extracting structured data from large volumes of scientific and clinical literature, with a particular strength in generating matrix-style evidence tables. It addresses the bottleneck of manual literature screening and data extraction, where regulatory and evidence teams must sift through hundreds of papers and clinical trial records to build consistent evidence matrices for submissions, reviews, and internal decision-making. By combining semantic search over millions of papers and clinical trials with large language models that extract and organise key study characteristics into configurable tables, the tool reduces reliance on line-by-line manual abstraction while keeping source-linked transparency for subsequent verification.
At a high level, Elcit (often spelled this way) uses machine learning and language models to identify relevant studies, pull out predefined variables such as population, interventions, outcomes, and study design, and then assemble these into evidence matrices that can be filtered and adapted to specific regulatory or evidence questions. This capability enables researchers and evidence teams to move more quickly from initial scoping to a structured view of the literature, shortening the early stages of systematic reviews and regulatory evidence packages and reducing the administrative load associated with repeated data entry. In practice, this can translate into materially faster timelines for building or updating evidence tables and improved decision quality, as teams are able to explore a broader evidence base in the same amount of time while maintaining a consistent, structured representation of key study attributes.
Last checked on May 19, 2026: Newly launched Elicit Systematic Review workflow and clinical-trials–aware features, plus SOC 2 Type II certification, strengthen its role as an AI platform for evidence synthesis and systematic reviews.
What is Elicit?
Elicit is an AI-powered research assistant that searches, summarises, and extracts structured data from scientific and clinical literature for regulatory and evidence-related use cases in discovery and matrix extraction. It is primarily used by researchers, evidence synthesis teams, and regulatory-focused analysts who need to build or update evidence tables from large volumes of publications and trial reports. Elicit is differentiated by its use of large language models to generate configurable, source-linked evidence matrices, reducing manual abstraction effort while preserving traceability to the underlying studies.
Why Do Leading Healthcare Teams Trust Elicit?
-
Elicit is developed and operated by Ought, a US-based organisation that has been building and maintaining the platform as an AI research assistant for several years, indicating product and company continuity.
-
The tool is used by academic, clinical, and industry researchers for evidence synthesis and literature workflows, and is recommended or described in guidance from universities and research libraries, which supports its credibility as a research-grade tool.
-
Elicit provides a Data Processing Addendum that references compliance with applicable data protection and privacy laws, including GDPR where relevant, and clarifies roles and responsibilities as controller/processor for customer data.
-
The platform emphasises source-linked outputs, with AI-generated claims tied back to sentence-level citations from underlying papers, supporting traceability and auditability of evidence matrices.
-
Public evaluations and methodological papers have assessed Elicit as a semi-automated support tool in systematic reviewing and evidence workflows, showing active scrutiny by the research community rather than functioning as an untested black-box system.
-
Elicit’s documentation and university guides highlight limitations, responsible-use guidance, and expectations about human oversight, indicating an explicit stance that AI outputs should be reviewed rather than used autonomously in high-stakes decisions.
-
No evidence was found of formal medical device approvals (such as FDA clearance or CE marking) or sector-specific certifications (such as HIPAA-specific attestations), which suggests it should currently be treated as a research and productivity tool rather than regulated clinical decision support.
-
The service is offered as a cloud-based web application with contractual and data protection documentation available, giving institutional buyers artefacts they can review as part of procurement and information governance processes.
Share This AI Tool
Get a neutral, no obligation view of whether this AI tool fits your portfolio
